Supported employment vs other vocational approachesEmployment ‐ job tenure for any paid employment (weeks) ‐ long term · adults with severe mental illness1 finding from 1 reviewSupported employment for adults with severe mental illness 2013 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 423 participantsVery low
Supported employment vs other vocational approachesTime (days) to first competitive employment ‐ long term · adults with severe mental illness1 finding from 1 reviewSupported employment for adults with severe mental illness 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 204 participantsVery low
Atypical antipsychotics vs placebo (only short term)Weight gain · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 107 participantsModerate
Atypical vs atypical antipsychotics (only short term)No improvement (clozapine vs olanzapine) · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 39 participantsHigh
Atypical vs atypical antipsychotics (only short term)Use of other antipsychotics · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 28 participantsModerate
Atypical vs atypical antipsychotics (only short term)Drug‐induced diabetes (clozapine vs olanzapine) · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 28 participantsModerate
Atypical vs atypical antipsychotics (only short term)Elevated prolactin (risperidone vs quetiapine) · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 22 participantsModerate
Atypical vs atypical antipsychotics (only short term)Weight gain · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 76 participantsHigh
Atypical vs atypical antipsychotics (only short term)Leaving the study early because of weight gain (risperidone vs olanzapine) · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 19 participantsLow
Atypical (standard‐dose) vs atypical (low‐dose) antipsychotics (only short term)No response · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 255 participantsHigh
Atypical (standard‐dose) vs atypical (low‐dose) antipsychotics (only short term)Symptomatic hyperprolactinaemia · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 257 participantsHigh
Atypical (standard‐dose) vs atypical (low‐dose) antipsychotics (only short term)Use of antiparkinsonian medications · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 257 participantsHigh
Atypical (standard‐dose) vs atypical (low‐dose) antipsychotics (only short term)Weight gain · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 257 participantsHigh
Atypical antipsychotics vs placebo (only short term)Weight gain (equal or greater then 7% of baseline) · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 106 participantsHigh
Atypical antipsychotics vs placebo (only short term)High prolactin at any time during treatment · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 107 participantsHigh
Atypical antipsychotics vs placebo (only short term)Change in corrected QT · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 107 participantsHigh
Atypical vs typical antipsychotics (only short term)Worse or no improvement · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 21 participantsLow
Atypical vs typical antipsychotics (only short term)Adverse effects ‐ anticholinergic effects · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 40 participantsModerate
Atypical vs typical antipsychotics (only short term)Drop in the absolute neutrophil count below 1500 per mm3 · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 21 participantsVery low
Atypical vs typical antipsychotics (only short term)Adverse effects: Leaving the study early · people with psychosis1 finding from 1 reviewAtypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 21 participantsModerate